Abstract:Background and purpose:Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is one of the ASPP family. It binds to p53 to inhibit the transcriptional activity of p53-target genes and cell apoptosis, which is asso-ciated with tumor formation. Previously, we found a new subtype of iASPP, iASPP splice variant (iASPP-SV), which is a nuclear protein containing 407 amino acid residues and can bind to p53, inhibiting p53 transcriptional activity. However, the relationship of iASPP-SV and breast cancer is still obscure. Therefore, the purpose of this research was to study the role of iASPP-SV on breast cancer tumorigenesis and progression.Methods:5’-rapid ampliifcation of cDNA ends (RACE) was used to identify the 5’-end of iASPP-SV mRNA in MCF-7 cells. HEK 293 cells were transfected with pFLAG-iASPP-SV and pFLAG-iASPP (828). Then Western blot was used to identify whether endogenous iASPP-SV was expressed in HEK 293 cells and 8 types of human tumor cell lines. This study established the stable clones of NIH 3T3 expressing FLAG-iASPP-SV and FLAG-iASPP (828). Cell proliferation assay, colony formation and soft agar colony formation assay were used to identify whether iASPP-SV and iASPP (828) can promote cell proliferation and iASPP-SV is an oncogene. Real-time lfuorescent quantitative polymerase chain reactive (RTFQ-PCR) was used to de-tect the levels of iASPP-SV and iASPP (828) mRNA in primary breast cancers. Luciferase assays were used to identify the relationships between iASPP-SV, iASPP (828), p53 and NF-κB p65.Results:The study identiifed that iASPP-SV was encoded by previously reported NF-κB p65 subunit (RelA)-associated inhibitor (RAI), and endogenously expressed in many human cancer cell lines. Analysis of cell proliferation, colony formation assay and soft agar assay for colony formation identiifed that similarly to iASPP (828), iASPP-SV promoted tumor cell proliferation and acted as an onco-gene. RTFQ-PCR result showed that the median values of iASPP-SV and iASPP (828) in breast cancers with wild-type p53 were more signiifcantly over-expressed than those of mutant p53. Luciferase assays showed that iASPP-SV and iASPP (828) could suppress NF-κB p65 transcriptional activity. Thus iASPP family may participate in the regulation of p53 and NF-κB activity, which imply that iASPP perhaps shows pro- or anti-survival activities when it interacts with different proteins.Conclusion:These ifndings indicate that iASPP-SV may be a potential target for breast cancer thera-py.

iASPP on apoptosis in breast cancer cells which expressed wild type p53

Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells.

Iaspp-Sv, As an Oncogene, Participates in Breast Tumorigenesis and Progression

Change From Promotion To Inhibition On Apoptosis In Hepatoma Cells Transferred Wild-Type P53 Gene

iASPP-SV, an Important iASPP isoform, participated in breast tumorigenesis/progression

Iaspp Oncoprotein is A Key Inhibitor of P53 Conserved from Worm to Human

Expression Pattern of the Apoptosis-Stimulating Protein of P53 Family in P53+ Human Breast Cancer Cell Lines

siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.

Iasppsv Antagonizes Apoptosis Induced by Chemotherapeutic Agents in MCF-7 Cells and Mouse Thymocytes

An iASPP‐derived short peptide restores p53‐mediated cell death in cancers with wild‐type p53

Effect of Iaspp on the Anti-Apoptosis and Genomic Instability of MCF-7

The Isomer ΔASPP2 Abrogates ASPP2-promoted P53 Apoptosis

Down-Regulation Of Iaspp In Human Hepatocellular Carcinoma Cells Inhibits Cell Proliferation And Tumor Growth

Iaspp is Over-Expressed in Human Non-Small Cell Lung Cancer and Regulates the Proliferation of Lung Cancer Cells Through a P53 Associated Pathway

Silencing of ASPP 2 Promotes the Proliferation , Migration and Invasion of Triple-Negative Breast Cancer Cells Via the PI 3 K / AKT Pathway

Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors

Iaspp Overexpression is Associated with Clinical Outcome in Spinal Chordoma and Influences Cellular Proliferation, Invasion, and Sensitivity to Cisplatin in Vitro.

Downregulation of Inhibitor of Apoptosis-Stimulating Protein of P53 Inhibits Proliferation and Promotes Apoptosis of Gastric Cancer Cells

Nuclear Iaspp Determines Cell Fate by Selectively Inhibiting Either P53 or NF-κB

A Previously Identified Apoptosis Inhibitor Iaspp Confers Resistance to Chemotherapeutic Drugs by Suppressing Senescence in Cancer Cells

Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53.